Edesa Biotech Statistics

Total Valuation

Edesa Biotech has a market cap or net worth of $15.42 million. The enterprise value is $2.91 million.

Market Cap	15.42M
Enterprise Value	2.91M

Important Dates

The last earnings date was Friday, August 8, 2025, after market close.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Edesa Biotech has 7.04 million shares outstanding. The number of shares has increased by 50.37% in one year.

Current Share Class	7.04M
Shares Outstanding	7.04M
Shares Change (YoY)	+50.37%
Shares Change (QoQ)	+32.36%
Owned by Insiders (%)	9.52%
Owned by Institutions (%)	1.69%
Float	3.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.10
P/TBV Ratio	5.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.97

Current Ratio	18.97
Quick Ratio	18.80
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.64% and return on invested capital (ROIC) is -47.29%.

Return on Equity (ROE)	-69.64%
Return on Assets (ROA)	-40.22%
Return on Invested Capital (ROIC)	-47.29%
Return on Capital Employed (ROCE)	-45.61%
Revenue Per Employee	n/a
Profits Per Employee	-$369,951
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Edesa Biotech has paid $800 in taxes.

Income Tax	800
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.49% in the last 52 weeks. The beta is 0.27, so Edesa Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-52.49%
50-Day Moving Average	2.12
200-Day Moving Average	2.19
Relative Strength Index (RSI)	49.25
Average Volume (20 Days)	24,195

Short Selling Information

The latest short interest is 6,405, so 0.09% of the outstanding shares have been sold short.

Short Interest	6,405
Short Previous Month	16,099
Short % of Shares Out	0.09%
Short % of Float	0.18%
Short Ratio (days to cover)	0.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-6.45M
Pretax Income	-6.93M
Net Income	-5.92M
EBITDA	-6.38M
EBIT	-6.45M
Earnings Per Share (EPS)	-$1.25

Full Income Statement

Balance Sheet

The company has $12.36 million in cash and n/a in debt, giving a net cash position of $12.36 million or $1.76 per share.

Cash & Cash Equivalents	12.36M
Total Debt	n/a
Net Cash	12.36M
Net Cash Per Share	$1.76
Equity (Book Value)	14.13M
Book Value Per Share	0.70
Working Capital	12.09M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.57M
Capital Expenditures	n/a
Free Cash Flow	-6.57M
FCF Per Share	-$0.93

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Edesa Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-50.37%
Shareholder Yield	-50.37%
Earnings Yield	-38.76%
FCF Yield	-43.01%

Analyst Forecast

The average price target for Edesa Biotech is $13.00, which is 493.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	493.44%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 11, 2023. It was a reverse split with a ratio of 1:7.

Last Split Date	Oct 11, 2023
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	1